Abstract
We sought to determine whether the Val(158)Met polymorphism in the catechol-O-methyltransferase (COMT) gene influences neurodegeneration within dopamine-innervated brain regions. A total of 252 subjects, including healthy controls and patients with Alzheimer disease, behavioral variant frontotemporal dementia, and semantic dementia, underwent COMT genotyping and structural MRI. Whole-brain voxel-wise regression analyses revealed that COMT Val(158)Met Val allele dosage, known to produce a dose-dependent decrease in synaptic dopamine (DA) availability, correlated with decreased gray matter in the region of the ventral tegmental area (VTA), ventromedial prefrontal cortex, bilateral dorsal midinsula, left dorsolateral prefrontal cortex, and right ventral striatum. Unexpectedly, patients carrying a Met allele showed greater VTA volumes than age-matched controls. Gray matter intensities within COMT-related brain regions correlated with cognitive and behavioral deficits. The results are consistent with the hypothesis that increased synaptic DA catabolism promotes neurodegeneration within DA-innervated brain regions.
References
May 1, 1997·Neurology·J L Cummings
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Jan 24, 2002·Neurology·H J RosenB L Miller
Jan 22, 2003·Neuroscience·M MatsumotoD R Weinberger
Oct 1, 2004·American Journal of Human Genetics·Jingshan ChenDaniel R Weinberger
Oct 19, 2004·Neuroscience Letters·Barbara BorroniAlessandro Padovani
Apr 12, 2005·Nature Neuroscience·Andreas Meyer-LindenbergKaren Faith Berman
Mar 11, 2008·Biological Psychology·André AlemanSophie van Rijn
Jul 19, 2008·NeuroImage·Katharina SchmackJürgen Gallinat
Aug 30, 2008·Neurobiology of Aging·J B RoweA M Owen
Oct 14, 2008·NeuroImage·Gerard R RidgwayNick C Fox
Dec 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jean-Claude DreherKaren Faith Berman
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Federica AgostaMaria Luisa Gorno-Tempini
Apr 21, 2009·Neuron·William W SeeleyMichael D Greicius
May 13, 2009·Neurology·J M S PereiraP J Nestor
May 19, 2009·Neuroscience·D Dickinson, B Elvevåg
Sep 19, 2009·Brain : a Journal of Neurology·Jennifer L WhitwellKeith A Josephs
Oct 9, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Suzanne N Haber, Brian Knutson
Dec 30, 2009·Cerebral Cortex·Estela CamaraThomas F Münte
Apr 20, 2010·NeuroImage·E Pomarol-ClotetR Salvador
Sep 23, 2010·Journal of Alzheimer's Disease : JAD·Alessandro PadovaniBarbara Borroni
Citations
Aug 1, 2012·Current Neurology and Neuroscience Reports·Masood Manoochehri, Edward D Huey
Sep 17, 2013·PloS One·Xuting XuShiwei Duan
Oct 23, 2013·PloS One·Tian TianChunshui Yu
Mar 2, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Antonio Verdejo-GarcíaRafael de la Torre
Oct 10, 2012·Current Opinion in Neurology·Kristin M Pearson-FuhrhopSteven C Cramer
Jan 27, 2016·Journal of the Neurological Sciences·Weiqian YanBeisha Tang
Dec 11, 2014·International Journal of Geriatric Psychiatry·Nobuto ShibataHeii Arai
Apr 17, 2015·BMC Neurology·Jennifer S YokoyamaGiovanni Coppola
Sep 23, 2016·PloS One·Ruth de Diego-BalaguerUNKNOWN French Speaking Huntington Group
Nov 2, 2016·Frontiers in Behavioral Neuroscience·Laura Del HoyoUNKNOWN TESDAD Study Group
Sep 5, 2017·Acta Neurologica Scandinavica·D BäckströmL Forsgren
Jun 14, 2017·Brain Imaging and Behavior·Xuejuan YangWei Qin
May 14, 2020·The Journal of Neuropsychiatry and Clinical Neurosciences·Edward D HueyJordan Grafman
Oct 1, 2020·Brain and Behavior·Tian TianWenzhen Zhu
May 24, 2020·Journal of Alzheimer's Disease : JAD·Rachel FremontEdward D Huey
Mar 30, 2020·The Journal of Nervous and Mental Disease·Edward D Huey
Sep 3, 2021·Neurobiology of Aging·Lauren MassimoCorey T McMillan